Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beauchamp

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Molecular Cancer Therapeutics|October 26, 2014
Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursorsElspeth M Beauchamp, Ewa M Kosciuczuk, Ruth Serrano, et al.
Chemical Biology & Drug Design|July 2, 2019
Discovery of novel Mnk inhibitors using mutation-based induced-fit virtual high-throughput screeningRama K Mishra, Matthew R Clutter, Gavin T Blyth, et al.
Canadian Journal of Dietetic Practice and Research : a Publication of Dietitians of Canada = Revue Canadienne De La Pratique Et De La Recherche En Dietetique : Une Publication Des Dietetistes Du Canada|September 24, 2025
Assessment of Scientific Literacy Skill Development Essential for Evidence-Based Practice During Combined Dietetic Practicum Training and Graduate-Level CourseworkKelsey Van, Rachel K Von Holt, David M Beauchamp, et al.
Molecular Cancer Therapeutics|July 25, 2015
NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination TherapyChunxiao Xu, Kevin A Buczkowski, Yanxi Zhang, et al.
Journal of Medical Virology|January 1, 1993
Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virusD J Purifoy, L M Beauchamp, P de Miranda, et al.
Blood Cancer Journal|March 4, 2021
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemiaBartholomew J Eisfelder, Caner Saygin, Joseph Wynne, et al.
Blood Neoplasia|June 24, 2025
Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AMLSara H Small, Ricardo E Perez, Elspeth M Beauchamp, et al.
Plos One|November 17, 2011
Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic miceGülay Bulut, Shannon Fallen, Elspeth M Beauchamp, et al.
Molecular Cancer Therapeutics|December 4, 2013
Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 lossEllen M Beauchamp, Brittany A Woods, Austin M Dulak, et al.
Blood|June 17, 2016
Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivoEwa M Kosciuczuk, Diana Saleiro, Barbara Kroczynska, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Molecular Cancer Therapeutics|October 26, 2014
Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursorsElspeth M Beauchamp, Ewa M Kosciuczuk, Ruth Serrano, et al.
Chemical Biology & Drug Design|July 2, 2019
Discovery of novel Mnk inhibitors using mutation-based induced-fit virtual high-throughput screeningRama K Mishra, Matthew R Clutter, Gavin T Blyth, et al.
Canadian Journal of Dietetic Practice and Research : a Publication of Dietitians of Canada = Revue Canadienne De La Pratique Et De La Recherche En Dietetique : Une Publication Des Dietetistes Du Canada|September 24, 2025
Assessment of Scientific Literacy Skill Development Essential for Evidence-Based Practice During Combined Dietetic Practicum Training and Graduate-Level CourseworkKelsey Van, Rachel K Von Holt, David M Beauchamp, et al.
Molecular Cancer Therapeutics|July 25, 2015
NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination TherapyChunxiao Xu, Kevin A Buczkowski, Yanxi Zhang, et al.
Journal of Medical Virology|January 1, 1993
Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virusD J Purifoy, L M Beauchamp, P de Miranda, et al.
Blood Cancer Journal|March 4, 2021
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemiaBartholomew J Eisfelder, Caner Saygin, Joseph Wynne, et al.
Blood Neoplasia|June 24, 2025
Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AMLSara H Small, Ricardo E Perez, Elspeth M Beauchamp, et al.
Plos One|November 17, 2011
Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic miceGülay Bulut, Shannon Fallen, Elspeth M Beauchamp, et al.
Molecular Cancer Therapeutics|December 4, 2013
Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 lossEllen M Beauchamp, Brittany A Woods, Austin M Dulak, et al.
Blood|June 17, 2016
Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivoEwa M Kosciuczuk, Diana Saleiro, Barbara Kroczynska, et al.
Pageof 12